Ivax Will Not Settle Lexapro Patent Challenge
This article was originally published in The Pink Sheet Daily
Executive Summary
Ivax denies speculation that it is in discussions with Forest to settle patent litigation regarding Forest's antidepressant Lexapro (escitalopram)